Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2003
03/13/2003US20030050447 Polypeptide for use in the generation of vaccine against diphtheria toxin
03/13/2003US20030050445 Flavor active modified thaumatin and monellin and methods for their production and use
03/13/2003US20030050442 62 human secreted proteins
03/13/2003US20030050440 Gene regulating aureobasidin sensitivity
03/13/2003US20030050264 Inhibiting binding of repressor factor to a Site C repressor binding site located in the TERT(telomerase reverse transciptase) minimal promoter for upregulating, the expression of telomerase reverse transcriptase
03/13/2003US20030050241 Extracellular proteins, secreted proteins, membrane-bound proteins; nucleic acid molecules encoding these polypeptides, as well as vectors and host cells having those nucleic acid sequences; fusion to heterologous polypeptides; antibodies
03/13/2003US20030050240 Extracellular proteins, secreted proteins, membrane-bound proteins; nucleic acid molecules encoding these polypeptides, as well as vectors and host cells having those nucleic acid sequences; fusion to heterologous polypeptides; antibodies
03/13/2003US20030050239 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050235 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
03/13/2003US20030050230 A nucleic acid encoding a family (title) of kinases from a group of sixteen polypeptides; identifying a substance that modulates kinase activity; autoimmune diseases; organ transplantation, cardiovascular disease, stroke, renal failure
03/13/2003US20030049831 Protein for use in the prevention of infections
03/13/2003US20030049828 Oncogenic protein for use in the diagnosis and treatment of tumors
03/13/2003US20030049827 Subtilisin variants
03/13/2003US20030049817 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment, and prevention of tumors and cell proliferation disorders
03/13/2003US20030049816 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment, and prevention of tumors and cell proliferation disorders
03/13/2003US20030049813 Extraction of protein or peptide from plant; obtain plant, homogenize, adjust hydrogen ion concentration, heat, centrifuge, suspend pellet, purify protein
03/13/2003US20030049801 Production of recombinant proteins in vivo and use for generating antibodies
03/13/2003US20030049800 Compositions and methods for producing antibodies to low molecular weight analytes
03/13/2003US20030049791 Goodpasture antigen binding protein
03/13/2003US20030049790 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
03/13/2003US20030049784 Tissue factor for use in the treatment of clotting, thrombotic, cardiovascular and cancer disorders
03/13/2003US20030049783 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049782 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049781 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049780 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferation and tumor disorders
03/13/2003US20030049778 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049777 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049776 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049775 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049773 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049772 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049771 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049770 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049769 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049768 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049767 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049766 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049763 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049762 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049761 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049760 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049759 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049758 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049757 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049756 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049750 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049749 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049748 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049747 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049746 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049745 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049744 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049743 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
03/13/2003US20030049742 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative, nervous system and tumor disorders
03/13/2003US20030049741 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049740 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative, nervous system and tumor disorders
03/13/2003US20030049739 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049735 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049734 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049733 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative, tumor, nervous system, arthritis, graft-versus-host disease, stroke, psoriasis and inflammatory bowel disease
03/13/2003US20030049732 Apoptosis related polynucleotides, polypeptides, and antibodies
03/13/2003US20030049731 Plasmid for use as tool in genetic engineering and heterologous gen expression
03/13/2003US20030049728 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049723 MAGE-A3 peptides presented by HLA class II molecules
03/13/2003US20030049715 Peptide biomarker and method of identification
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049699 Polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049694 Production of fusion proteins and use for identifying binding molecules
03/13/2003US20030049685 Synthetic antigens for the detection of antibodies to hepatitis C virus
03/13/2003US20030049684 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2003US20030049683 Rationally designed antibodies
03/13/2003US20030049682 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2003US20030049681 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049677 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049676 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2003US20030049661 Proteins for use in the treatment and diagnosis of brain and nervous system disorders
03/13/2003US20030049648 37 staphylococcus aureus genes and polypeptides
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049638 Nucleotide sequences coding polypeptide for use in the treatment and prevention of cell proliferative, nervous system and tumor disorders
03/13/2003US20030049633 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049621 Secreted and transmembrane polypeptides and nucleic acids enconding the same
03/13/2003US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
03/13/2003US20030049607 Protein complex for use in controlling viral propagation in cells
03/13/2003US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases
03/13/2003US20030049601 Detecting hepatitis in sample; obtain sample, incubate with binding agent, detect complex, presence of complex indicate hepatitis virus
03/13/2003US20030049265 Heliobacter pylori antigen
03/13/2003US20030049261 Administering chitinase inhibitor
03/13/2003US20030049260 Method of improving cognitive function
03/13/2003US20030049259 Control of lymphocyte localization by LEEP-CAM activity
03/13/2003US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/13/2003US20030049257 Anticancer agents; administering interleukin polypeptide
03/13/2003US20030049256 Cytokine antagonists for neurological and neuropsychiatric disorders
03/13/2003US20030049254 Modulating neuronal outgrowth via the major histocompatibility complex Class I (MHC I) molecule
03/13/2003US20030049252 Controlling immunology response; autoimmune disease, antiallergens
03/13/2003US20030049251 Methods and compositions useful for inhibiting ccr5-dependent infection of cells by hiv-1
03/13/2003US20030049249 Therapy, prevention prion infections; using monoclonal antibodies encapsulated as hybridomas
03/13/2003US20030049227 Antitumor, anticarcinogenic agents; using fusion protein
1 ... 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 ... 1494